Catalyst Event
Eli Lilly and Co (LLY) · Other
From Akros U.S. Large Cap 500 Index (AUL500)
3/19/2026, 12:00:00 AM
Eli Lilly announced positive top-line results from its TRANSCEND-T2D-1 Phase 3 trial for retatrutide, a next-generation obesity and diabetes drug. The study showed significant reductions in both A1C levels and body weight in adults with type 2 diabetes, expected. High importance is estimated as positive Phase 3 results for a major drug typically result in a price impact exceeding 10%.
Korean Translation
일라이 릴리, 차세대 비만 및 당뇨병 치료제 레타트루타이드의 TRANSCEND-T2D-1 3상 임상시험에서 긍정적인 탑라인 결과를 발표함. 해당 연구는 제2형 당뇨병 성인 환자에서 당화혈색소(A1C) 수치와 체중 모두에서 유의미한 감소를 보임, 예상됨. 주요 약물의 긍정적인 3상 결과는 통상적으로 10% 이상의 주가 영향을 미치므로 중요도를 '높음'으로 예상함.
Related Recent Events
ON Semiconductor Corp (ON) · Other
The company announced it will host its Financial Analyst Day on September 16, 2026, to provide updates on company strategy, growth initiatives, and its long-term financial plan. A low impact is estimated as such events typically provide incremental information. This event is scheduled.
9/16/2026, 12:00:00 AM
Adobe Inc (ADBE) · Earnings Release
Adobe's Q2 2026 earnings release is scheduled for June 12, 2026, which is expected to have a high market impact (>=10%) as it provides the next official update on financial performance scheduled.
6/12/2026, 12:00:00 AM
Dell Technologies Inc (DELL) · Earnings Release
Dell Technologies Fiscal Year 2027 First Quarter results scheduled.
5/28/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision on LEQEMBI IQLIK (subcutaneous) for treatment initiation is scheduled. The FDA granted Priority Review for this supplemental Biologics License Application, with a PDUFA action date of May 24, 2026, which is expected. This event is expected to have a high price impact due to the significant market potential of the new delivery method.
5/24/2026, 12:00:00 AM
Vertiv Holdings Co (VRT) · Other
Vertiv will host its 2026 Investor Conference from May 19-20, 2026, where management will provide updates on strategic initiatives and market trends, and this is expected to cause moderate price volatility, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
The next quarterly earnings release on 2026-05-14 is scheduled.
5/14/2026, 12:00:00 AM